Literature DB >> 18347999

Different etiological role of Helicobacter pylori (Hp) infection in carcinogenesis between differentiated and undifferentiated gastric cancers: a nested case-control study using IgG titer against Hp surface antigen.

Masayuki Tatemichi1, Shizuka Sasazuki, Manami Inoue, Shoichiro Tsugane.   

Abstract

BACKGROUND: The present study epidemiologically clarified the different roles of Helicobacter pylori (Hp) infection in carcinogenesis between two major histological types of noncardia gastric cancer (ncGC), intestinal (=differentiated) and diffuse (=undifferentiated), by analyzing IgG antibody titer against Hp surface antigen on the data set of a nested case-control study in a large cohort study conducted in Japan.
METHODS: A total of 36,745 subjects aged 40 to 69 years in the Japan Health Center-based prospective study who responded to the baseline questionnaire and provided blood were followed over 15 years; 350 ncGC cases (differentiated=242, undifferentiated=108) matched to controls were used. Using baseline blood samples, plasma IgG titer was measured using ELISA. The level of IgG titer >10 U (cut-off value) was classified into three grades in groups of equal number: low, middle, and high.
RESULTS: IgG titer of Hp was significantly (p<0.01) higher in undifferentiated cases than in differentiated ones. Among the three grades of Hp IgG titer, the high titer was more closely associated with risk of undifferentiated ncGC (odds ratio (OR) for high=7.8, 95% confidence interval (CI)=2.4-24.9 vs. OR for low=6.4, 95% CI=2.1-19.6), while the low titer was a better predictor of differentiated ncGC (OR for high=3.2, 95% CI=1.6-6.4 vs. OR for low=5.9, 95% CI=3.0-11.6, trend p < 0.05). The high titer group had the lowest risk to develop differentiated ncGC with <7 years (OR=3.2, 95% CI=1.3-7.7), whereas the high titer group demonstrated the highest risk for undifferentiated ncGC developing (OR=11.6 95% CI=2.3-59.1).
CONCLUSION: Our study epidemiologically confirmed that atrophic changes caused by Hp infection determine the development of differentiated-type ncGC, and the inflammation itself induced by Hp infection promotes the development of undifferentiated-type ncGC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18347999     DOI: 10.1080/02841860701843035

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  11 in total

Review 1.  Helicobacter pylori and gastric cancer.

Authors:  Hidekazu Suzuki; Eisuke Iwasaki; Toshifumi Hibi
Journal:  Gastric Cancer       Date:  2009-06-27       Impact factor: 7.370

2.  Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk.

Authors:  Hironori Masuyama; Naoto Yoshitake; Takako Sasai; Tetsuya Nakamura; Atsushi Masuyama; Toru Zuiki; Kentaro Kurashina; Mitsuyo Mieda; Keijiro Sunada; Hironori Yamamoto; Kazutomo Togashi; Akira Terano; Hideyuki Hiraishi
Journal:  Digestion       Date:  2015-01-20       Impact factor: 3.216

3.  Tests for serum levels of trefoil factor family proteins can improve gastric cancer screening.

Authors:  Susumu Aikou; Yasukazu Ohmoto; Toshiaki Gunji; Nobuyuki Matsuhashi; Hiroshi Ohtsu; Hirona Miura; Kensuke Kubota; Yukinori Yamagata; Yasuyuki Seto; Atsushi Nakajima; James R Goldenring; Michio Kaminishi; Sachiyo Nomura
Journal:  Gastroenterology       Date:  2011-05-27       Impact factor: 22.682

Review 4.  Aspirin use and the risk of gastric cancer: a meta-analysis.

Authors:  Ping Yang; Yong Zhou; Bo Chen; Hong-Wei Wan; Gui-Qing Jia; Hai-Long Bai; Xiao-Ting Wu
Journal:  Dig Dis Sci       Date:  2009-08-12       Impact factor: 3.199

5.  A multicenter observational study on the clinicopathological features of gastric cancer in young patients.

Authors:  Yoshiyasu Kono; Hiromitsu Kanzaki; Takao Tsuzuki; Masahiro Takatani; Junichirou Nasu; Daisuke Kawai; Ryuta Takenaka; Takehiro Tanaka; Masaya Iwamuro; Seiji Kawano; Yoshiro Kawahara; Toshiyoshi Fujiwara; Hiroyuki Okada
Journal:  J Gastroenterol       Date:  2018-10-29       Impact factor: 7.527

6.  Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology.

Authors:  Eun Jeong Gong; Ji Young Lee; Suh Eun Bae; Young Soo Park; Kee Don Choi; Ho June Song; Gin Hyug Lee; Hwoon-Yong Jung; Woo Jin Jeong; Gab Jin Cheon; Jeong Hwan Yook; Byung Sik Kim
Journal:  PLoS One       Date:  2018-04-05       Impact factor: 3.240

7.  The Characteristics and Prognosis of Diffuse-Type Early Gastric Cancer Diagnosed during Health Check-Ups.

Authors:  Ji Young Lee; Eun Jeong Gong; Eun Ju Chung; Hye Won Park; Suh Eun Bae; Eun Hee Kim; Jaeil Kim; Yoon Suh Do; Tae Hyup Kim; Hye-Sook Chang; Ho June Song; Jaewon Choe; Hwoon-Yong Jung
Journal:  Gut Liver       Date:  2017-11-15       Impact factor: 4.519

8.  Analysis of negative result in serum anti-H. pylori IgG antibody test in cases with gastric mucosal atrophy.

Authors:  Kyoichi Adachi; Tomoko Mishiro; Shino Tanaka; Yoshikazu Kinoshita
Journal:  J Clin Biochem Nutr       Date:  2016-06-10       Impact factor: 3.114

Review 9.  Helicobacter pylori Antibody Titer and Gastric Cancer Screening.

Authors:  Hiroshi Kishikawa; Kayoko Kimura; Sakiko Takarabe; Shogo Kaida; Jiro Nishida
Journal:  Dis Markers       Date:  2015-09-30       Impact factor: 3.434

10.  Serum anti-Helicobacter pylori antibody titer and its association with gastric nodularity, atrophy, and age: A cross-sectional study.

Authors:  Osamu Toyoshima; Toshihiro Nishizawa; Kosuke Sakitani; Tadahiro Yamakawa; Yoshiyuki Takahashi; Nobutake Yamamichi; Keisuke Hata; Yasuyuki Seto; Kazuhiko Koike; Hidenobu Watanabe; Hidekazu Suzuki
Journal:  World J Gastroenterol       Date:  2018-09-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.